In this system, addition of the inhibitor alone reduced distance travelled in both donor and IPF fibroblasts and mitigated the effect of exogenous heparin + FGF1 in IPF fibroblasts when added simultaneously. The gene discussed is FGF1; the disease is idiopathic pulmonary fibrosis.